Virtual Library

Start Your Search

  • WCLC 2018

    19th World Conference on Lung Cancer

    Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON

    Presentation Date(s):  
    • Sept 23 - 26, 2018
    • Total Presentations: 2384

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    YI01 - Young Investigators Session

    • Type: Young Investigator Session
    • Track:
    • Presentations: 18
    • Coordinates: 9/23/2018, 08:00 - 11:30, Room 106
  • +

    PL02 - Presidential Symposium - Top 5 Abstracts

    • Type: Plenary Session
    • Track: Advanced NSCLC
    • Presentations: 11
    • Coordinates: 9/25/2018, 08:15 - 09:45, Plenary Hall
  • +

    MA12 - Mesothelioma Surgery and Novel Targets for Prognosis and Therapy

    • Type: Mini Oral Abstract Session
    • Track: Mesothelioma
    • Presentations: 12
    • Coordinates: 9/25/2018, 10:30 - 12:00, Room 202 BD
    • +

      MA12.05 - Phase 1 Study of HSP90 Inhibitor Ganetespib with Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma

      11:00 - 11:05  |  Presenter: Dean A Fennell

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.06 - Mesothelioma (Not CME Accredited Session)

    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 41
    • Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
    • +

      P2.06-09 - MiST3: A Phase II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in pts with Malignant Mesothelioma

      16:45 - 18:00  |  Author(s): Matthew G Krebs

      • Abstract

      Loading...